/C O R R E C T I O N from source - AEterna Zentaris Inc./
April 25 2007 - 1:06PM
PR Newswire (US)
In MO460 "AEterna Zentaris to Announce First Quarter 2007 Financial
and Operating Results on May 2, 2007" transmitted at 07:30e today,
an error occurred in the last line of the second paragraph which
should have read "800-591-7539" and not "800-361-1022". Full
corrected copy follows : AEterna Zentaris to Announce First Quarter
2007 Financial and Operating Results on May 2, 2007 QUEBEC CITY,
April 25 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ;
Nasdaq: AEZS), a global biopharmaceutical company focused on
endocrine therapy and oncology, announced today that it will
release its first quarter 2007 financial and operating results on
May 2, 2007, before market open. The Company will host a conference
call and webcast to discuss these results on Wednesday, May 2, 2007
at 4:00 p.m. (Eastern). Investors and interested parties may access
the live webcast via the Company's website at
http://www.aeternazentaris.com/ in the "investors" section, or via
telephone using the following numbers: 514-807-8791, 416-644-3428
or 800-591-7539. A replay of the webcast will also be available on
the Company's website for a period of 30 days. About AEterna
Zentaris Inc. AEterna Zentaris Inc. is a global biopharmaceutical
company focused on endocrine therapy and oncology with proven
expertise in drug discovery, development and commercialization.
News releases and additional information are available at
http://www.aeternazentaris.com/. DATASOURCE: AETERNA ZENTARIS INC.
CONTACT: Jenene Thomas, Senior Director, Investor Relations &
Corporate Communications, (418) 655-6420, ; Paul Burroughs, Media
Relations, (418) 652-8525 ext. 406,
Copyright